Table 2.
Breakdown of the medicines used in the mono-VPA and poly-VPA groups.
| Group | Mono | Poly |
|---|---|---|
| Number of medications | ||
| 1 | 10 [100] | |
| 2 | — | 5 [45] |
| 3 | — | 4 [36] |
| 4 | — | 1 [9] |
| 7 | — | 1 [9] |
| Antiepileptic drugs | ||
| Valproate | 10 [100] | 11 [100] |
|
Valproate blood level (µg/mL)* |
53.9 ± 15.8 | 65.7 ± 21.4 |
| Carbamazepine | — | 4 [36] |
| Phenytoin | 3 [27] | |
| Phenobarbital | — | 1 [9] |
| Clobazam | — | 1 [9] |
| Clonazepam | — | 1 [9] |
| Levetiracetam | — | 1 [9] |
| Zonisamide | — | 1 [9] |
| Antipsychotic drugs | ||
| Risperidone | 2 [18] | |
| Quetiapine | — | 1 [9] |
| Biperiden | — | 1 [9] |
| Pimozide | — | 1 [9] |
| Paliperidone | — | 1 [9] |
| Haloperidol | — | 1 [9] |
| Aripiprazole | 1 [9] | |
| Antidepressant drugs | ||
| Etizolam | — | 1 [9] |
| Fluvoxamine | — | 1 [9] |
Data are presented as absolute [percentage] or mean ± SD* values.
Mono: mono-VPA group, Poly: poly-VPA group.